Supplementary Data 1 from A novel class of Ribosome Modulating Agents (RMAs) exploits cancer ribosome heterogeneity to selectively target the CMS2 subtype of colorectal cancer

DOI: 10.1158/2767-9764.22795650 Publication Date: 2023-05-10T16:10:32Z